Orally active chelator that promotes urinary iron excretion. Prepn: M. Yasue et al., Yakugaku Zasshi 90, 1222 (1970), C.A. 74, 23102b (1971); G. J. Kontoghiorghes et al., Arzneim.-Forsch. 37, 1099 (1987). Iron binding studies: idem, Inorg. Chim. Acta 135, 145 (1987). HPLC determn in serum and urine: B. Dresow et al., J. Anal. Chem. 352, 562 (1995). Clinical pharmacokinetics: F. N. Al-Refaie et al., Br. J. Haematol. 89, 403 (1995). Clinical studies in transfusional iron overload: idem et al., ibid. 91, 224 (1995); N. F. Olivieri et al., N. Engl. J. Med. 332, 918 (1995). Review of pharmacology and clinical experience: G. J. Kontoghiorghes, Ann. N.Y. Acad. Sci. 612, 339-350 (1990); F. N. Al-Refaie, A. V. Hoffbrand, Baill. Clin. Haematol. 7, 941-963 (1994); of toxicology: G. J. Kontoghiorghes, Toxicol. Lett. 80, 1-18 (1995).
Chelating agent (iron and aluminum).
Chelating Agent